Indeed, autophagy regulation has been proposed as a therapy to reduce the risk of obesity-associated cardiovascular diseases (Castaneda et al. 2019). Thus, ATG2A may participate in a positive feedback loop in which lower expression of ATG2A is both a cause and a consequence of obesity. This evidence concerns the gene ATG2A and obesity disorder.